Literature DB >> 6651371

Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity.

R E Chambers, D G MacFarlane, J T Whicher, P A Dieppe.   

Abstract

The serum concentrations of serum amyloid-A protein (SAA), C-reactive protein (CRP), and alpha 1-acid glycoprotein (alpha 1-AGP) have been measured in 185 patients with rheumatoid arthritis. SAA and CRP concentrations correlated well (r = 0.86) both within and above the normal ranges, though SAA showed a greater incremental increase than CRP. All patients with normal SAA levels also had normal CRP and alpha 1-AGP concentrations. In contrast, in 40% of patients with normal CRP and alpha 1-AGP concentrations the SAA was raised, sometimes markedly so. The clinical and serological assessments of disease activity in these patients were not significantly different from those with concomitantly raised levels of CRP. These findings suggest that SAA is a more sensitive marker of inflammation than is CRP. The role of the measurement of SAA as a monitor for inflammatory disease activity is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651371      PMCID: PMC1001325          DOI: 10.1136/ard.42.6.665

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  Quantitation of "acute-phase proteins" postoperatively. Value in detection and monitoring of complications.

Authors:  C L Fischer; C Gill; M G Forrester; R Nakamura
Journal:  Am J Clin Pathol       Date:  1976-11       Impact factor: 2.493

Review 2.  The value of complement assays in clinical chemistry.

Authors:  J T Whicher
Journal:  Clin Chem       Date:  1978-01       Impact factor: 8.327

3.  Amyloid-related serum component (SAA)--studies in acute infections, medullary thyroid carcinoma, and postsurgery.

Authors:  P D Gorevic; C J Rosenthal; E C Franklin
Journal:  Clin Immunol Immunopathol       Date:  1976-07

4.  The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.

Authors:  B McConkey; R A Crockson; A P Crockson
Journal:  Q J Med       Date:  1972-04

5.  The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis.

Authors:  B McConkey; R A Crockson; A P Crockson; A R Wilkinson
Journal:  Q J Med       Date:  1973-10

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

8.  Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases.

Authors:  M D Benson; A S Cohen
Journal:  Arthritis Rheum       Date:  1979-01

9.  Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.

Authors:  K P McAdam; R J Elin; J D Sipe; S M Wolff
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

10.  Variation with age and disease of an amyloid A protein-related serum component.

Authors:  C J Rosenthal; E C Franklin
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

View more
  30 in total

1.  Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation.

Authors:  R E Chambers; C W Hutton; P A Dieppe; J T Whicher
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

2.  Sulphur bath and mud pack treatment for rheumatoid arthritis at the Dead Sea area.

Authors:  S Sukenik; D Buskila; L Neumann; A Kleiner-Baumgarten; S Zimlichman; J Horowitz
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

3.  Increased serum amyloid A in nasal polyps is associated with systemic corticosteroid insensitivity in patients with chronic rhinosinusitis with nasal polyps: a pilot study.

Authors:  Hangui Lu; Xin-Sheng Lin; Dan-Mian Yao; Ying-Ying Zhuang; Guo-Feng Wen; Jianbo Shi; Yue-Qi Sun
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-25       Impact factor: 2.503

4.  Antifungal Activity of Mammalian Serum Amyloid A1 against Candida albicans.

Authors:  Jiao Gong; Jun Wu; Melanie Ikeh; Li Tao; Yulong Zhang; Jian Bing; Clarissa J Nobile; Guanghua Huang
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

5.  Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis.

Authors:  M D Chard; J Calvin; C P Price; T E Cawston; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

6.  Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.

Authors:  Rong L He; Jian Zhou; Crystal Z Hanson; Jia Chen; Ni Cheng; Richard D Ye
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

7.  Serum amyloid A protein in acute viral infections.

Authors:  H Miwata; T Yamada; M Okada; T Kudo; H Kimura; T Morishima
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

8.  Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A.

Authors:  Ni Cheng; Rong He; Jun Tian; Patrick P Ye; Richard D Ye
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza.

Authors:  J T Whicher; R E Chambers; J Higginson; L Nashef; P G Higgins
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

10.  Serum amyloid P component and autoimmune parameters in the assessment of arthritis activity in MRL/lpr/lpr mice.

Authors:  C Rordorf-Adam; D Serban; A Pataki; M Grüninger
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.